Bortezomib Plus Gemcitabine/Carboplatin as First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S0339)
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181915052
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2009
Authors
Publisher
Elsevier BV